DE69704031T2 - Test zur diagnose eines erhöhten brustkrebs-risikos - Google Patents

Test zur diagnose eines erhöhten brustkrebs-risikos

Info

Publication number
DE69704031T2
DE69704031T2 DE69704031T DE69704031T DE69704031T2 DE 69704031 T2 DE69704031 T2 DE 69704031T2 DE 69704031 T DE69704031 T DE 69704031T DE 69704031 T DE69704031 T DE 69704031T DE 69704031 T2 DE69704031 T2 DE 69704031T2
Authority
DE
Germany
Prior art keywords
breast cancer
sequence
diagnosis
test
cancer risk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69704031T
Other languages
English (en)
Other versions
DE69704031D1 (de
Inventor
R Jupe
F Thompson
Regina Resta
Orco T Dell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Oklahoma Medical Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation filed Critical Oklahoma Medical Research Foundation
Application granted granted Critical
Publication of DE69704031D1 publication Critical patent/DE69704031D1/de
Publication of DE69704031T2 publication Critical patent/DE69704031T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
DE69704031T 1996-11-07 1997-11-06 Test zur diagnose eines erhöhten brustkrebs-risikos Expired - Fee Related DE69704031T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2997896P 1996-11-07 1996-11-07
PCT/US1997/020844 WO1998020167A1 (en) 1996-11-07 1997-11-06 Diagnostic assay for breast cancer susceptibility

Publications (2)

Publication Number Publication Date
DE69704031D1 DE69704031D1 (de) 2001-03-08
DE69704031T2 true DE69704031T2 (de) 2001-06-13

Family

ID=21851898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69704031T Expired - Fee Related DE69704031T2 (de) 1996-11-07 1997-11-06 Test zur diagnose eines erhöhten brustkrebs-risikos

Country Status (8)

Country Link
US (1) US6355427B1 (de)
EP (1) EP0943017B1 (de)
JP (1) JP2001503276A (de)
AT (1) ATE199025T1 (de)
AU (1) AU723400B2 (de)
CA (1) CA2269664C (de)
DE (1) DE69704031T2 (de)
WO (1) WO1998020167A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024614A1 (en) * 1997-11-06 1999-05-20 Oklahoma Medical Research Foundation Diagnostic assay for cancer susceptibility
CA2336595A1 (en) * 1998-07-24 2000-02-03 Oklahoma Medical Research Foundation Use of prohibitin rna in treatment of cancer
US7273855B2 (en) 1999-07-24 2007-09-25 Oklahoma Medical Research Foundation Use of prohibitin RNA in treatment of cancer
US7238475B2 (en) * 2001-08-27 2007-07-03 The Regents Of The University Of California Apolipoprotein gene involved in lipid metabolism
EP2135960A1 (de) * 2001-09-19 2009-12-23 Intergenetics Incorporated Genetische Analyse zur Stratifizierung eines Krebsrisikos mit Hilfe des Allelprofils der VDR-ApaI und CYP11b2 Gene
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
KR20070039930A (ko) 2004-07-08 2007-04-13 엑손모빌 케미칼 패턴츠 인코포레이티드 초임계 조건에서 중합체의 제조방법
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
JP5394069B2 (ja) * 2005-11-29 2014-01-22 ケンブリッジ エンタープライズ リミテッド 乳癌についてのマーカー
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
MX2011012913A (es) 2009-06-01 2012-02-21 Genetic Technologies Ltd Métodos para evaluar el riesgo de cáncer de mama.
EP2611943B1 (de) 2010-09-03 2017-01-04 Wake Forest University Health Sciences Verfahren und zusammensetzungen zur korrelation genetischer marker mit prostatakrebsgefahr
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
AU2015327756B2 (en) 2014-09-30 2018-01-04 Genetic Technologies Limited Methods for assessing risk of developing breast cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271294A (ja) 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするｄｎａ
US5922852A (en) * 1995-06-07 1999-07-13 Oklahoma Medical Research Foundation 3' untranslated region of the human prohibitin gene

Also Published As

Publication number Publication date
JP2001503276A (ja) 2001-03-13
WO1998020167A1 (en) 1998-05-14
US6355427B1 (en) 2002-03-12
AU7002398A (en) 1998-05-29
EP0943017B1 (de) 2001-01-31
CA2269664A1 (en) 1998-05-14
CA2269664C (en) 2007-08-07
EP0943017A1 (de) 1999-09-22
ATE199025T1 (de) 2001-02-15
AU723400B2 (en) 2000-08-24
DE69704031D1 (de) 2001-03-08

Similar Documents

Publication Publication Date Title
DE69704031T2 (de) Test zur diagnose eines erhöhten brustkrebs-risikos
Manwell et al. Genetic distance between the Australian Merino and the Poll Dorset sheep
NZ331376A (en) Methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
WO2000004187A3 (en) Methods and kits for diagnosing and determination of the predisposition of diseases
GB2383043A (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
DE69733958D1 (de) Verfahren zur positionierung von klonen mittels molekularen kaemmens
DK1323728T3 (da) Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster
ATE360092T1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
Emadian et al. Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
ATE164630T1 (de) Verfahren und reagenzien für die karakterisierung von hla-drbeta-dns
DK0515660T3 (da) HLA-DQbeta-DNA-typebestemmelse
Okamoto et al. Polymorphism of 5-methylcytosine-rich DNA in human acrocentric chromosomes
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
Smith et al. Biomarkers in the molecular epidemiology of benzene-exposed workers
Harada et al. New phenotypes of serum α 1-antitrypsin in Japanese detected by gel slab isoelectric focusing
FI990380A0 (fi) Diagnostinen ja seulontamenetelmä
CA2308766A1 (en) Diagnostic assay for cancer susceptibility
Yasuda et al. Population studies of human deoxyribonuclease I polymorphism
Wu et al. Detection of minimal residual disease in childhood acute lymphoblastic leukemia after termination of therapy
KR960705062A (ko) Cmv 핵산 증폭 및 검출용 프라이머와 프로브(primers and probes for the amplification and detection of cmv nucleic acid)
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
Benez et al. Morphologically intact melanoma cells may be detected in peripheral blood of melanoma patients
Pastori et al. Factor V Leiden Thrombophilia
DE60237406D1 (de) Aus einem Neuroblastom isolierte Nukleinsäuren

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee